| Item Type | Name |
|
Academic Article
|
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
|
|
Academic Article
|
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
|
|
Concept
|
Fluorouracil
|
|
Academic Article
|
Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.
|
|
Academic Article
|
The activity of paclitaxel in gastrointestinal tumors.
|
|
Academic Article
|
Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
|
|
Academic Article
|
Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
|
|
Academic Article
|
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
|
|
Academic Article
|
Phase II study of prolonged infusion of Taxol in patients with metastatic colorectal carcinoma.
|
|
Academic Article
|
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
|
|
Academic Article
|
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
|
|
Academic Article
|
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
|
|
Academic Article
|
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
|
|
Academic Article
|
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
|
|
Academic Article
|
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
|
|
Academic Article
|
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
|
|
Academic Article
|
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.
|
|
Academic Article
|
Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.
|
|
Academic Article
|
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.
|
|
Academic Article
|
Low dose, continuous infusion 5-fluorouracil plus radiotherapy for anal cancer.
|
|
Academic Article
|
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
|
|
Academic Article
|
Radiotherapy for anal cancer: experience from 1979-1987.
|
|
Academic Article
|
High-dose methotrexate and 5-fluorouracil in patients with advanced colorectal carcinoma. A randomized study of two pretreatment intervals.
|
|
Academic Article
|
Bolus fluorouracil for metastatic colorectal carcinoma?
|
|
Academic Article
|
Fluorouracil-associated dermatitis of the hands and feet.
|
|
Academic Article
|
High dose external beam radiation therapy with or without concomitant chemotherapy for esophageal carcinoma.
|
|
Academic Article
|
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
|
|
Academic Article
|
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
|
|
Academic Article
|
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction.
|
|
Academic Article
|
Standard chemotherapy for gastric carcinoma: is it a myth?
|
|
Academic Article
|
A pilot study of preoperative chemoradiotherapy for resectable gastric cancer.
|
|
Academic Article
|
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
|
|
Academic Article
|
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
|
|
Academic Article
|
Treatment of colorectal cancer metastasis: the role of chemotherapy.
|
|
Academic Article
|
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
|
|
Academic Article
|
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
|
|
Academic Article
|
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
|
|
Academic Article
|
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.
|
|
Academic Article
|
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
|
|
Academic Article
|
Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy.
|
|
Academic Article
|
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
|
|
Academic Article
|
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
|
|
Academic Article
|
Anal carcinoma therapy: can we improve on 5-fluorouracil/mitomycin/radiotherapy?
|
|
Academic Article
|
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
|
|
Academic Article
|
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
|
|
Academic Article
|
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.
|
|
Academic Article
|
Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.
|
|
Academic Article
|
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.
|
|
Academic Article
|
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
|
|
Academic Article
|
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
|
|
Academic Article
|
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.
|
|
Academic Article
|
Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinoma.
|
|
Academic Article
|
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer.
|
|
Academic Article
|
Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin.
|
|
Academic Article
|
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
|
|
Academic Article
|
Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.
|
|
Academic Article
|
Treatment of patients with upper gastrointestinal carcinomas.
|
|
Academic Article
|
Chemotherapy for gastric carcinoma: new and old options.
|
|
Academic Article
|
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
|
|
Academic Article
|
Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
|
|
Academic Article
|
Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
|
|
Academic Article
|
Preoperative therapy for patients with resectable squamous cell carcinoma of the esophagus: are we still confused?
|
|
Academic Article
|
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
|
|
Academic Article
|
Docetaxel-based chemotherapy in the treatment of gastric cancer.
|
|
Academic Article
|
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.
|
|
Academic Article
|
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
|
|
Academic Article
|
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
|
|
Academic Article
|
Treatment issues in pediatric gastric adenocarcinoma.
|
|
Academic Article
|
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
|
|
Academic Article
|
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
|
|
Academic Article
|
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
|
|
Academic Article
|
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.
|
|
Academic Article
|
Pharmacogenetics in esophageal cancer.
|
|
Academic Article
|
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
|
|
Academic Article
|
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study.
|
|
Academic Article
|
Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
|
|
Academic Article
|
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
|
|
Academic Article
|
Current treatment for localized anal carcinoma.
|
|
Academic Article
|
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
|
|
Academic Article
|
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
|
|
Academic Article
|
Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?
|
|
Academic Article
|
Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen.
|
|
Academic Article
|
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer.
|
|
Academic Article
|
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
|
|
Academic Article
|
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
|
|
Academic Article
|
A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
|
|
Academic Article
|
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study.
|
|
Academic Article
|
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
|
|
Academic Article
|
Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance.
|
|
Academic Article
|
Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.
|
|
Academic Article
|
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
|
|
Academic Article
|
Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor.
|
|
Academic Article
|
Medical treatment for advanced gastroesophageal adenocarcinoma.
|
|
Academic Article
|
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
|
|
Academic Article
|
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
|
|
Academic Article
|
Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
|
|
Academic Article
|
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
|
|
Academic Article
|
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
|
|
Academic Article
|
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.
|
|
Academic Article
|
Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.
|
|
Academic Article
|
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
|
|
Academic Article
|
Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
|
|
Academic Article
|
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
|
|
Academic Article
|
18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.
|
|
Academic Article
|
American Society of Clinical Oncology, 45th Annual Meeting - Comparison of cisplatin/S-1 tablets with cisplatin/5-FU infusions for advanced gastric cancer
|
|
Academic Article
|
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction
|
|
Academic Article
|
Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma
|
|
Academic Article
|
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.
|
|
Academic Article
|
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction.
|
|
Academic Article
|
Final Results of NRG Oncology RTOG 0246: An?Organ-Preserving Selective Resection Strategy in?Esophageal Cancer Patients Treated with Definitive?Chemoradiation.
|
|
Academic Article
|
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
|
|
Academic Article
|
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
|
|
Academic Article
|
Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency.
|
|
Academic Article
|
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer.
|
|
Academic Article
|
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.
|
|
Academic Article
|
Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma.
|
|
Academic Article
|
Taxane- Versus Cisplatin-Based Chemotherapy With Radiation Therapy Is a Better Platform to Refine Esophageal Cancer Therapy.
|
|
Academic Article
|
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.
|
|
Academic Article
|
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
|
|
Academic Article
|
Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.
|
|
Academic Article
|
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors.
|
|
Academic Article
|
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
|
|
Academic Article
|
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
|
|
Academic Article
|
Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing?
|
|
Academic Article
|
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529.
|